USPTO Examiner GOLDBERG RICHMEI ANNA E - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18715976BREAST PUMP WITH VIBRATION UNIT AND HEATERJune 2024June 2025Allow1321YesNo
18630860IV EXTRAVASATION DETECTION DEVICEApril 2024January 2025Allow910NoNo
18410218Method and Device for the Treatment of GlaucomaJanuary 2024June 2024Allow520YesNo
18405795VALVE AND RELATED METHODSJanuary 2024October 2024Allow921YesNo
18488828APPLICATOR FOR IMPLANT INSERTIONOctober 2023March 2025Allow1720YesNo
17964149INTELLIGENT MEDICATION DELIVERY SYSTEMS AND METHODSOctober 2022June 2024Allow2010NoNo
17835709Flow Control SystemJune 2022March 2024Allow2110YesNo
17730302NEEDLE POSITION INDICATORApril 2022December 2023Allow1920YesNo
17559777INJECTION DEVICE WITH OUTER CAP WITH NEEDLE PROTECTION CAP REMOVAL ELEMENT AND METHOD FOR ASSEMBLING AN INJECTION DEVICEDecember 2021July 2024Allow3120YesNo
17533126BALLOON CATHETERNovember 2021May 2025Abandon4220YesNo
17454958Systems and Methods for Percutaneous Intravascular Access and Guidewire PlacementNovember 2021May 2025Allow4220NoNo
17494084SYSTEM(S), METHOD(S) AND DEVICE(S) FOR THE PREVENTION OF ESOPHAGEAL FISTULA DURING CATHETER ABLATIONOctober 2021June 2023Allow2010NoNo
17593049MICRONEEDLE HAVING STRUCTURE OF THREE OR MORE LAYERS, AND METHOD FOR MANUFACTURING SAMESeptember 2021November 2024Abandon3801NoNo
17400560DRUG SOLUTION DELIVERY APPARATUSAugust 2021January 2025Allow4210NoNo
17392330THREE POSITION NEEDLE RETRACTIONAugust 2021August 2023Allow2520NoNo
17421986SYSTEM FOR LYOPHILIZING, RECONSTITUTING, AND DELIVERING A MEDICATION, AND RELATED METHODSJuly 2021May 2025Abandon4611NoNo
17352797APPARATUS AND METHODS FOR EVERTING CATHETERS WITH EXPANDABLE LUMENSJune 2021March 2024Abandon3340NoNo
17343129CONNECTION UNIT FOR AIR FEEDING TUBE, AND METHOD OF FEEDING AIR INTO CONNECTION UNIT FOR AIR FEEDING TUBEJune 2021June 2024Allow3711YesNo
17337238INTRAVENOUS CATHETER DEVICE WITH SLIDING SAFETY MECHANISMJune 2021August 2023Allow2710YesNo
17320554CONNECTED INJECTION DEVICES WITH STATUS SENSING SYSTEMSMay 2021September 2023Allow2810YesNo
17319943ASPIRATION CATHETER SYSTEMS AND METHODS OF USEMay 2021June 2024Allow3800NoNo
17222798BALLOON GUIDING SHEATH HAVING A TEXTURED SURFACEApril 2021September 2024Allow4230YesNo
17216124CATHETER TUBE AND METHOD FOR MANUFACTURING THE SAMEMarch 2021October 2023Abandon3110NoNo
17214496APPARATUS AND METHODS FOR EVERTING CATHETERS WITH EXPANDABLE LUMENSMarch 2021May 2024Abandon3831YesYes
17279783LASER-MARKED MEDICAL COMPONENTS FROM ELASTOMERSMarch 2021March 2025Allow4822YesNo
17128125PUSH-TYPE SAFETY PROTECTION MECHANISM OF BLOOD COLLECTION NEEDLEDecember 2020February 2024Abandon3810NoNo
17096319EXPANDABLE-TIP ASPIRATION GUIDE CATHETERNovember 2020September 2023Allow3410YesNo
17052299METHOD FOR ASCERTAINING THE VERTICAL DISTANCE BETWEEN A PATIENT (LEVEL OF SURGICAL INTERVENTION) AND A FLUID DELIVERY PUMPNovember 2020January 2025Allow5020YesNo
17032903SERVICE LOOP RINGSeptember 2020January 2024Allow4041YesNo
17030015INTRAVENOUS FILTERSeptember 2020February 2023Allow2910NoNo
17018955BREAST MILK COLLECTION AND STORAGE CONTAINERS AND SYSTEMS THEREOFSeptember 2020February 2024Allow4111NoNo
17014140CATHETER INCLUDING A BAMBOO STRUCTURAL SUPPORT MEMBERSeptember 2020May 2025Abandon5640YesNo
16977936Medical Infusion Pump for Delivery of a FluidSeptember 2020January 2023Allow2930NoNo
17001330PORTABLE INFUSION PUMP WITH PINCH/SQUEEZE PUMPING ACTIONAugust 2020February 2024Abandon4230NoNo
16932292INSUFFLATOR, CONNECTOR FOR INSUFFLATOR, AND INSUFFLATION APPARATUSJuly 2020November 2023Allow4020YesNo
16906744EXCHANGEABLE CARTRIDGE FOR AN INJECTION DEVICEJune 2020March 2023Allow3310YesNo
16884716Line Protecting GarmentMay 2020March 2023Abandon3420YesNo
16879485Ambulatory Medical Pump Cartridge Locking SystemMay 2020March 2023Allow3410NoNo
16764294STATUS SENSING SYSTEMS WITHIN AN INJECTION DEVICE ASSEMBLYMay 2020March 2021Allow1010YesNo
16761521DRUG DELIVERY DEVICE WITH PLACEMENT AND FLOW SENSINGMay 2020May 2025Abandon6050YesNo
16862947Surgical Insufflation Systems and Methods for UseApril 2020May 2025Allow6070YesNo
16825309INTRAVASCULAR CATHETER WITH SENSOR SYSTEMSMarch 2020March 2024Abandon4830NoNo
16802317CATHETER WITH SEAMLESS FLEXIBILITY TRANSITIONSFebruary 2020February 2022Abandon2310NoNo
16793917COUPLING BETWEEN A TELESCOPING NEEDLE SHIELD AND A CATHETER ADAPTERFebruary 2020May 2024Allow5160YesNo
16792595MEDICAL DEVICE AND METHOD OF OPERATING A MEDICAL DEVICE AND DETECTION OF A SHORT CIRCUITFebruary 2020June 2023Allow4030YesNo
16790568Alternative Fluid-Driven Articulation Architecture for Catheters and Other UsesFebruary 2020February 2024Abandon4821YesNo
16787279MULTI-COMPONENT SAFETY NEEDLE COVERFebruary 2020August 2022Allow3021YesNo
16781609IV Extravasation Detection DeviceFebruary 2020December 2023Allow4661YesNo
16752350ASYMMETRICAL BALLOON CATHETERJanuary 2020August 2022Abandon3110NoNo
16747148PRESSURE INFUSION DEVICE FOR RETAINING INFUSION BAG AND ADJUSTABLE GRAVITY-INDEPENDENT OPERATION THEREOFJanuary 2020May 2023Abandon4030YesNo
16732787REDUCED DEAD SPACE CATHETER ADAPTERJanuary 2020July 2022Allow3030YesNo
16615284CATHETERNovember 2019October 2024Abandon5960NoNo
16689340VANE PUMP FOR MEDICAL INSTRUMENTNovember 2019January 2024Allow5040NoNo
16519406Modular Warming System for Dialysis FluidJuly 2019March 2024Allow5640YesNo
16436496FLEXIBLE CANNULA AND PROCESSJune 2019June 2024Allow6070YesNo
16465621STEERABLE ENDOSCOPE WITH CONTINUUM MANIPULATORMay 2019August 2023Allow5030YesNo
16413336HIGH-PRESSURE BALLOON CATHETERS AND METHODSMay 2019August 2023Abandon5151NoNo
16404842ENTERAL FEEDING PUMP AND TUBING SETMay 2019June 2023Abandon4940NoNo
16392697Fluid Line Connector Devices Methods and SystemsApril 2019February 2022Abandon3420NoNo
16333226MICRONEEDLE ARRAYMarch 2019February 2022Abandon3520NoNo
16299579DEVICE, SYSTEM AND METHOD FOR TREATING A EUSTACHIAN TUBEMarch 2019April 2022Abandon3720NoNo
16330910PRESSURE REGULATION SYSTEMMarch 2019September 2021Allow3110NoNo
16278403MEDICAL SYRINGE FOR PREVENTING NEEDLE-STICK INJURYFebruary 2019June 2022Abandon4021NoNo
16278625DEFLECTABLE SHEATH WITH INFLATABLE BALLOONFebruary 2019May 2022Abandon3950NoNo
16276685Transesophageal Catheter With Carbon Dioxide Delivery System For Thermal Protection Of EsophagusFebruary 2019November 2023Abandon5760NoNo
16262326PROTECTIVE NEEDLE CAPJanuary 2019June 2021Abandon2810NoNo
16259797INJECTION DEVICE WITH OUTER CAP WITH NEEDLE PROTECTION CAP REMOVAL ELEMENT AND METHOD FOR ASSEMBLING AN INJECTION DEVICEJanuary 2019January 2022Allow3521YesNo
16259524EXTERNAL CAP HAVING NEEDLE PROTECTION CAP REMOVER ELEMENT AND METHOD FOR ASSEMBLING AN INJECTION DEVICEJanuary 2019November 2021Allow3421YesNo
16317396MEDICAL DEVICE INCLUDING A PACKAGE AND A PRE-FILLED SYRINGE DISPOSED IN THE PACKAGEJanuary 2019February 2021Allow2510NoNo
16246432CATHETER FEEDERJanuary 2019February 2021Abandon2610NoNo
16229794SEGMENTED PISTON ROD FOR A MEDICATION DELIVERY DEVICEDecember 2018October 2021Allow3430YesNo
16229354CLOSURE ASSEMBLY HAVING A SNAP-FIT CONSTRUCTIONDecember 2018August 2022Allow4421YesNo
16229901COUPLING MECHANISM FOR A MEDICATION DELIVERY DEVICEDecember 2018July 2021Allow3020YesNo
16229212HIGH FLOW AT LOW PRESSURE INFUSION SYSTEM AND METHODDecember 2018May 2022Abandon4121YesNo
16216392Infusion Pump AssemblyDecember 2018June 2025Allow6091YesNo
16217032MEDICAL DEVICES INCLUDING RING MEMBERS AND CONNECTING MEMBERSDecember 2018November 2021Abandon3521NoNo
16302470THREE POSITION NEEDLE RETRACTIONNovember 2018April 2021Allow2911YesNo
16172190SYSTEMS, METHODS, AND DEVICES FOR DELIVERING SUBSTANCES INTO A FALLOPIAN TUBEOctober 2018March 2025Abandon6061NoNo
16168284SECONDARY LUMEN FOR RAPID DRUG INFUSIONOctober 2018May 2021Abandon3020NoNo
16168399NEEDLE INSERTION RESPONSIVE SYSTEMOctober 2018February 2022Abandon4030NoNo
16168316DOUBLE ACTION RIGID FLUID PATH CONNECTOROctober 2018October 2020Allow2410NoNo
16095787SMART MEDICATION DELIVERY DEVICES FOR PROVIDING USERS WITH DELIVERY INFOMATICS AND METHODS OF USING SAMEOctober 2018March 2023Allow5360YesNo
16091677MICRONEEDLE USING BIOABSORBABLE METALOctober 2018April 2022Abandon4240NoNo
16127427BALLOON CATHETER, METHOD OF MANUFACTURING A BALLOON CATHETER, AND TREATMENT METHODSeptember 2018September 2021Allow3621NoNo
16127586BALLOON CATHETER, METHOD OF MANUFACTURING A BALLOON CATHETER, AND TREATMENT METHODSeptember 2018May 2022Allow4441YesNo
16127461SYSTEM(S), METHOD(S) AND DEVICE(S) FOR THE PREVENTION OF ESOPHAGEAL FISTULA DURING CATHETER ABLATIONSeptember 2018September 2021Allow3721NoNo
16080565Flow Control SystemAugust 2018March 2022Allow4230YesNo
16112988DEVICES AND METHODS FOR TREATING BONE TISSUEAugust 2018September 2022Abandon4910NoNo
16110447METHOD AND APPARATUS OF ECHOGENIC CATHETER SYSTEMSAugust 2018April 2023Abandon5621YesNo
16100383CIRCUMFERENTIAL IRRIGATION METHOD OF SINUSITIS TREATMENTAugust 2018February 2021Abandon3011NoNo
16049388FLUID FLOW REGULATION ARRANGEMENTS FOR DRUG DELIVERY DEVICESJuly 2018January 2021Allow2911YesNo
16049106GARMENT SYSTEM PROVIDING BIOMETRIC AND ENVIRONMENTAL MONITORING FOR MEDICAL CONDITION ASSESSMENTJuly 2018January 2023Abandon5341YesNo
16066900SYRINGEJune 2018February 2022Allow4430YesNo
16063551Automatic Injection Device Having An Improved Cam PathJune 2018November 2020Abandon2910NoNo
16011003CLAMPING DEVICEJune 2018March 2021Allow3330YesNo
16060501Drug delivery device with removably attachable sensor deviceJune 2018August 2022Allow5050YesNo
16060855Fluid Line Connector Devices Methods and SystemsJune 2018July 2022Allow4921YesYes
16060679DEVICE FOR REMOVING AIR FROM AN ANATOMICAL CAVITY IN A SURGICAL INTERVENTIONJune 2018September 2020Abandon2810NoNo
16060564INJECTION DEVICE FOR INJECTING DOSED AMOUNTS OF A LIQUID THERAPEUTIC AGENTJune 2018June 2021Abandon3620NoNo
16004275INTELLIGENT MEDICATION DELIVERY SYSTEMS AND METHODSJune 2018June 2022Allow4940YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GOLDBERG-RICHMEI, ANNA E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
99.4%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
2
Allowed After Appeal Filing
1
(50.0%)
Not Allowed After Appeal Filing
1
(50.0%)
Filing Benefit Percentile
82.5%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner GOLDBERG-RICHMEI, ANNA E - Prosecution Strategy Guide

Executive Summary

Examiner GOLDBERG-RICHMEI, ANNA E works in Art Unit 3783 and has examined 112 patent applications in our dataset. With an allowance rate of 58.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner GOLDBERG-RICHMEI, ANNA E's allowance rate of 58.9% places them in the 13% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by GOLDBERG-RICHMEI, ANNA E receive 2.63 office actions before reaching final disposition. This places the examiner in the 88% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GOLDBERG-RICHMEI, ANNA E is 38 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +49.4% benefit to allowance rate for applications examined by GOLDBERG-RICHMEI, ANNA E. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.0% of applications are subsequently allowed. This success rate is in the 13% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 25.8% of cases where such amendments are filed. This entry rate is in the 27% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 21% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 16% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 85% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.0% of allowed cases (in the 71% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.